CAV1 and pulmonary arterial hypertension: These defects lead to disease conditions such as pulmonary arterial hypertension and congenital generalized lipodystrophy in the case of CAV1 mutants or sarcolemma damage and muscular dystrophies for CAV3 mutants (Copeland et al., 2017; Gonzalez Coraspe et al., 2018).